The latest price target for Anixa Biosciences (NASDAQ:ANIX) was reported by D. Boral Capital on June 10, 2025. The analyst firm set a price target for $10.00 expecting ANIX to rise to within 12 ...

An analyst from Maxim Group set a price target of 10.0 for ANIX. Skip to main content. Nasdaq+. Weekly Macro+. Scorecard. Market Activity. U.S. Market Activity-> Stocks; Options ...

Anixa Biosciences, Inc. ANIX was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a ...

Anixa has different exciting programs going on. Read why the June readout in the breast cancer vaccine trial may be an opportunity to trade ANIX if successful.

ANIX hopes to commercialize a vaccine targeting α-lactalbumin, a protein that gets expressed in triple-negative breast cancer but should normally only be present in mammary tissue during lactation.

Below, we take a look at ANIXA BIOSCIENCES INC (ANIX), a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the main ...

Below, we take a look at ANIXA BIOSCIENCES INC (ANIX), a company that currently holds a Momentum Style Score of A.We also talk about price change and earnings estimate revisions, two of the main ...